Huonslab has entered the final stage for the commercialization of its recombinant human hyaluronidase, with the aim of receiving approval in the second half of 2026.
11hon MSN
Oscar-hopeful Homebound faces copyright suit as author accuses Dharma and Netflix of plagiarism
Homebound, shortlisted for the 98th Academy Awards, faces legal action from author Puja Changoiwala, who claims the film ...
The global metagenomics sequencing market size was US$ 1139.3 million in 2021. The global metagenomics sequencing market is forecast to grow to US$ 3,994.01 million by 2030 by registering a compound ...
This article explores limitations of chemical synthesis in high-throughput settings and the technical advantages enzymatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback